Approved Treatment for Chagas Disease?
Chagas Disease, a deadly condition caused by the parasite, Trypanosoma cruzi, has emerged as a major vector-borne illness across the southern United States. A 2019 study of dogs in Texas showed that the seroprevalence of T. cruzi exceeded 18% – higher than D. immitus, Erhlichia spp, Anaplasma spp, and Borrelia spp.
Despite its increasing spread, Chagas disease has remained a poorly understood condition with no definitive treatment – until now. Texas’ own Dr. Roy Madigan recently was awarded the first and only patent for a drug to treat T. cruzi. Dr. Madigan has dedicated his career to researching and fighting Chagas disease, and this treatment brings hope that we’ll soon be able to easily save patients from this devastating disease.
Please join LSVA and Dr. Madigan this December to talk more about this novel therapy, and to learn how to effectively diagnose and treat this deadly emerging disease! This program, which offers 11 hours of RACE Approved CE, will be held live online December 5 and 6. Dr. Madigan will be joined by double-boarded specialist, Clarke Atkins, DVM, DACVIM (Cardiology and Internal Medicine), pathology enthusiast, Steve Jones, DVM, and heartworm preventive specialist, Carrie Everett, DVM, for fun and interactive discussion.
We expect this will be one of the most informative and interesting webinars you’ll attend all year! Space is limited, so make plans to attend today.
